Global Malabsorption Syndrome Market Size, Status and Forecast 2021-2027

吸収不良症候群の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Malabsorption Syndrome Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR3532
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:90
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、吸収不良症候群の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(栄養補助食品、プロテアーゼ・リパーゼサプリメント、抗生物質、止瀉薬、抗炎症薬、その他)、用途別市場規模(製薬会社、病院、栄養クリニック、学術・研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・吸収不良症候群の市場動向
・企業の競争状況、市場シェア
・吸収不良症候群の種類別市場規模(栄養補助食品、プロテアーゼ・リパーゼサプリメント、抗生物質、止瀉薬、抗炎症薬、その他)
・吸収不良症候群の用途別市場規模(製薬会社、病院、栄養クリニック、学術・研究所)
・吸収不良症候群の北米市場規模2016-2027(アメリカ、カナダ)
・吸収不良症候群の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・吸収不良症候群のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・吸収不良症候群の中南米市場規模2016-2027(メキシコ、ブラジル)
・吸収不良症候群の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbvie、Actelion Pharmaceuticals、Astrazeneca、Bayer Healthcare、Dsm、Eli Lily And Company、Gilead Sciences)
・結論

Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absorb enough of certain nutrients and fluids. These nutrients can be macronutrients (proteins, carbohydrates, and fats), micronutrients (vitamins and minerals), or both.
Treatment of Malabsorption is directed largely towards management of underlying cause. Replacement of nutrients, electrolytes and fluid may be necessary. In severe deficiency, hospital admission may be required for nutritional support and detailed advice from dietitians. Use of enteral nutrition by naso-gastric or other feeding tubes may be able to provide sufficient nutritional supplementation. Pancreatic enzymes are supplemented orally in pancreatic insufficiency. Dietary modification is important in some conditions including Gluten-free diet in coeliac disease and Lactose avoidance in lactose intolerance. Antibiotic therapy is used to treat Small Bowel Bacterial overgrowth.

Market Analysis and Insights: Global Malabsorption Syndrome Market
The global Malabsorption Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Malabsorption Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Malabsorption Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Malabsorption Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Malabsorption Syndrome market.

Global Malabsorption Syndrome Scope and Market Size
Malabsorption Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Malabsorption Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nutritional Supplements
Protease and Lipase Supplements
Antibiotics
Antidiarrheal Agents
Anti-inflammatory Drugs
Others

Segment by Application
Pharmaceutical Companies
Hospitals
Nutrition Clinics
Academic And Research Institutes

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbvie
Actelion Pharmaceuticals
Astrazeneca
Bayer Healthcare
Dsm
Eli Lily And Company
Gilead Sciences

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Malabsorption Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nutritional Supplements
1.2.3 Protease and Lipase Supplements
1.2.4 Antibiotics
1.2.5 Antidiarrheal Agents
1.2.6 Anti-inflammatory Drugs
1.2.7 Others
1.3 Market by Application
1.3.1 Global Malabsorption Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Nutrition Clinics
1.3.5 Academic And Research Institutes
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Malabsorption Syndrome Market Perspective (2016-2027)
2.2 Malabsorption Syndrome Growth Trends by Regions
2.2.1 Malabsorption Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Malabsorption Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Malabsorption Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Malabsorption Syndrome Industry Dynamic
2.3.1 Malabsorption Syndrome Market Trends
2.3.2 Malabsorption Syndrome Market Drivers
2.3.3 Malabsorption Syndrome Market Challenges
2.3.4 Malabsorption Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Malabsorption Syndrome Players by Revenue
3.1.1 Global Top Malabsorption Syndrome Players by Revenue (2016-2021)
3.1.2 Global Malabsorption Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Malabsorption Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Malabsorption Syndrome Revenue
3.4 Global Malabsorption Syndrome Market Concentration Ratio
3.4.1 Global Malabsorption Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Malabsorption Syndrome Revenue in 2020
3.5 Malabsorption Syndrome Key Players Head office and Area Served
3.6 Key Players Malabsorption Syndrome Product Solution and Service
3.7 Date of Enter into Malabsorption Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Malabsorption Syndrome Breakdown Data by Type
4.1 Global Malabsorption Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Malabsorption Syndrome Forecasted Market Size by Type (2022-2027)

5 Malabsorption Syndrome Breakdown Data by Application
5.1 Global Malabsorption Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Malabsorption Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Malabsorption Syndrome Market Size (2016-2027)
6.2 North America Malabsorption Syndrome Market Size by Type
6.2.1 North America Malabsorption Syndrome Market Size by Type (2016-2021)
6.2.2 North America Malabsorption Syndrome Market Size by Type (2022-2027)
6.2.3 North America Malabsorption Syndrome Market Size by Type (2016-2027)
6.3 North America Malabsorption Syndrome Market Size by Application
6.3.1 North America Malabsorption Syndrome Market Size by Application (2016-2021)
6.3.2 North America Malabsorption Syndrome Market Size by Application (2022-2027)
6.3.3 North America Malabsorption Syndrome Market Size by Application (2016-2027)
6.4 North America Malabsorption Syndrome Market Size by Country
6.4.1 North America Malabsorption Syndrome Market Size by Country (2016-2021)
6.4.2 North America Malabsorption Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Malabsorption Syndrome Market Size (2016-2027)
7.2 Europe Malabsorption Syndrome Market Size by Type
7.2.1 Europe Malabsorption Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Malabsorption Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Malabsorption Syndrome Market Size by Type (2016-2027)
7.3 Europe Malabsorption Syndrome Market Size by Application
7.3.1 Europe Malabsorption Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Malabsorption Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Malabsorption Syndrome Market Size by Application (2016-2027)
7.4 Europe Malabsorption Syndrome Market Size by Country
7.4.1 Europe Malabsorption Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Malabsorption Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Malabsorption Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Malabsorption Syndrome Market Size by Type
8.2.1 Asia-Pacific Malabsorption Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Malabsorption Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Malabsorption Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Malabsorption Syndrome Market Size by Application
8.3.1 Asia-Pacific Malabsorption Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Malabsorption Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Malabsorption Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Malabsorption Syndrome Market Size by Region
8.4.1 Asia-Pacific Malabsorption Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Malabsorption Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Malabsorption Syndrome Market Size (2016-2027)
9.2 Latin America Malabsorption Syndrome Market Size by Type
9.2.1 Latin America Malabsorption Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Malabsorption Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Malabsorption Syndrome Market Size by Type (2016-2027)
9.3 Latin America Malabsorption Syndrome Market Size by Application
9.3.1 Latin America Malabsorption Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Malabsorption Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Malabsorption Syndrome Market Size by Application (2016-2027)
9.4 Latin America Malabsorption Syndrome Market Size by Country
9.4.1 Latin America Malabsorption Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Malabsorption Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Malabsorption Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Malabsorption Syndrome Market Size by Type
10.2.1 Middle East & Africa Malabsorption Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Malabsorption Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Malabsorption Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Malabsorption Syndrome Market Size by Application
10.3.1 Middle East & Africa Malabsorption Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Malabsorption Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Malabsorption Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Malabsorption Syndrome Market Size by Country
10.4.1 Middle East & Africa Malabsorption Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Malabsorption Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Malabsorption Syndrome Introduction
11.1.4 Abbvie Revenue in Malabsorption Syndrome Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Actelion Pharmaceuticals
11.2.1 Actelion Pharmaceuticals Company Details
11.2.2 Actelion Pharmaceuticals Business Overview
11.2.3 Actelion Pharmaceuticals Malabsorption Syndrome Introduction
11.2.4 Actelion Pharmaceuticals Revenue in Malabsorption Syndrome Business (2016-2021)
11.2.5 Actelion Pharmaceuticals Recent Development
11.3 Astrazeneca
11.3.1 Astrazeneca Company Details
11.3.2 Astrazeneca Business Overview
11.3.3 Astrazeneca Malabsorption Syndrome Introduction
11.3.4 Astrazeneca Revenue in Malabsorption Syndrome Business (2016-2021)
11.3.5 Astrazeneca Recent Development
11.4 Bayer Healthcare
11.4.1 Bayer Healthcare Company Details
11.4.2 Bayer Healthcare Business Overview
11.4.3 Bayer Healthcare Malabsorption Syndrome Introduction
11.4.4 Bayer Healthcare Revenue in Malabsorption Syndrome Business (2016-2021)
11.4.5 Bayer Healthcare Recent Development
11.5 Dsm
11.5.1 Dsm Company Details
11.5.2 Dsm Business Overview
11.5.3 Dsm Malabsorption Syndrome Introduction
11.5.4 Dsm Revenue in Malabsorption Syndrome Business (2016-2021)
11.5.5 Dsm Recent Development
11.6 Eli Lily And Company
11.6.1 Eli Lily And Company Company Details
11.6.2 Eli Lily And Company Business Overview
11.6.3 Eli Lily And Company Malabsorption Syndrome Introduction
11.6.4 Eli Lily And Company Revenue in Malabsorption Syndrome Business (2016-2021)
11.6.5 Eli Lily And Company Recent Development
11.7 Gilead Sciences
11.7.1 Gilead Sciences Company Details
11.7.2 Gilead Sciences Business Overview
11.7.3 Gilead Sciences Malabsorption Syndrome Introduction
11.7.4 Gilead Sciences Revenue in Malabsorption Syndrome Business (2016-2021)
11.7.5 Gilead Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Malabsorption Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nutritional Supplements
Table 3. Key Players of Protease and Lipase Supplements
Table 4. Key Players of Antibiotics
Table 5. Key Players of Antidiarrheal Agents
Table 6. Key Players of Anti-inflammatory Drugs
Table 7. Key Players of Others
Table 8. Global Malabsorption Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Malabsorption Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Malabsorption Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Malabsorption Syndrome Market Share by Regions (2016-2021)
Table 12. Global Malabsorption Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Malabsorption Syndrome Market Share by Regions (2022-2027)
Table 14. Malabsorption Syndrome Market Trends
Table 15. Malabsorption Syndrome Market Drivers
Table 16. Malabsorption Syndrome Market Challenges
Table 17. Malabsorption Syndrome Market Restraints
Table 18. Global Malabsorption Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Malabsorption Syndrome Market Share by Players (2016-2021)
Table 20. Global Top Malabsorption Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malabsorption Syndrome as of 2020)
Table 21. Ranking of Global Top Malabsorption Syndrome Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Malabsorption Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Malabsorption Syndrome Product Solution and Service
Table 25. Date of Enter into Malabsorption Syndrome Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Malabsorption Syndrome Revenue Market Share by Type (2016-2021)
Table 29. Global Malabsorption Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Malabsorption Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Malabsorption Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Malabsorption Syndrome Revenue Market Share by Application (2016-2021)
Table 33. Global Malabsorption Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Malabsorption Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Malabsorption Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Malabsorption Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Malabsorption Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Malabsorption Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Malabsorption Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Malabsorption Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Malabsorption Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Malabsorption Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Malabsorption Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Malabsorption Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Malabsorption Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Malabsorption Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Malabsorption Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Malabsorption Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Malabsorption Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Malabsorption Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Malabsorption Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Malabsorption Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Malabsorption Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Malabsorption Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Malabsorption Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Malabsorption Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Malabsorption Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Malabsorption Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Malabsorption Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Malabsorption Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 65. Abbvie Company Details
Table 66. Abbvie Business Overview
Table 67. Abbvie Malabsorption Syndrome Product
Table 68. Abbvie Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 69. Abbvie Recent Development
Table 70. Actelion Pharmaceuticals Company Details
Table 71. Actelion Pharmaceuticals Business Overview
Table 72. Actelion Pharmaceuticals Malabsorption Syndrome Product
Table 73. Actelion Pharmaceuticals Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 74. Actelion Pharmaceuticals Recent Development
Table 75. Astrazeneca Company Details
Table 76. Astrazeneca Business Overview
Table 77. Astrazeneca Malabsorption Syndrome Product
Table 78. Astrazeneca Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 79. Astrazeneca Recent Development
Table 80. Bayer Healthcare Company Details
Table 81. Bayer Healthcare Business Overview
Table 82. Bayer Healthcare Malabsorption Syndrome Product
Table 83. Bayer Healthcare Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 84. Bayer Healthcare Recent Development
Table 85. Dsm Company Details
Table 86. Dsm Business Overview
Table 87. Dsm Malabsorption Syndrome Product
Table 88. Dsm Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 89. Dsm Recent Development
Table 90. Eli Lily And Company Company Details
Table 91. Eli Lily And Company Business Overview
Table 92. Eli Lily And Company Malabsorption Syndrome Product
Table 93. Eli Lily And Company Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 94. Eli Lily And Company Recent Development
Table 95. Gilead Sciences Company Details
Table 96. Gilead Sciences Business Overview
Table 97. Gilead Sciences Malabsorption Syndrome Product
Table 98. Gilead Sciences Revenue in Malabsorption Syndrome Business (2016-2021) & (US$ Million)
Table 99. Gilead Sciences Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Malabsorption Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Nutritional Supplements Features
Figure 3. Protease and Lipase Supplements Features
Figure 4. Antibiotics Features
Figure 5. Antidiarrheal Agents Features
Figure 6. Anti-inflammatory Drugs Features
Figure 7. Others Features
Figure 8. Global Malabsorption Syndrome Market Share by Application: 2020 VS 2027
Figure 9. Pharmaceutical Companies Case Studies
Figure 10. Hospitals Case Studies
Figure 11. Nutrition Clinics Case Studies
Figure 12. Academic And Research Institutes Case Studies
Figure 13. Malabsorption Syndrome Report Years Considered
Figure 14. Global Malabsorption Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Malabsorption Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Malabsorption Syndrome Market Share by Regions: 2020 VS 2027
Figure 17. Global Malabsorption Syndrome Market Share by Regions (2022-2027)
Figure 18. Global Malabsorption Syndrome Market Share by Players in 2020
Figure 19. Global Top Malabsorption Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malabsorption Syndrome as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Malabsorption Syndrome Revenue in 2020
Figure 21. Global Malabsorption Syndrome Revenue Market Share by Type (2016-2021)
Figure 22. Global Malabsorption Syndrome Revenue Market Share by Type (2022-2027)
Figure 23. North America Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Malabsorption Syndrome Market Share by Type (2016-2027)
Figure 25. North America Malabsorption Syndrome Market Share by Application (2016-2027)
Figure 26. North America Malabsorption Syndrome Market Share by Country (2016-2027)
Figure 27. United States Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Malabsorption Syndrome Market Share by Type (2016-2027)
Figure 31. Europe Malabsorption Syndrome Market Share by Application (2016-2027)
Figure 32. Europe Malabsorption Syndrome Market Share by Country (2016-2027)
Figure 33. Germany Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Malabsorption Syndrome Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Malabsorption Syndrome Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Malabsorption Syndrome Market Share by Region (2016-2027)
Figure 43. China Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Malabsorption Syndrome Market Share by Type (2016-2027)
Figure 51. Latin America Malabsorption Syndrome Market Share by Application (2016-2027)
Figure 52. Latin America Malabsorption Syndrome Market Share by Country (2016-2027)
Figure 53. Mexico Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Malabsorption Syndrome Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Malabsorption Syndrome Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Malabsorption Syndrome Market Share by Country (2016-2027)
Figure 59. Turkey Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Malabsorption Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Abbvie Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 63. Actelion Pharmaceuticals Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 64. Astrazeneca Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 65. Bayer Healthcare Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 66. Dsm Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 67. Eli Lily And Company Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 68. Gilead Sciences Revenue Growth Rate in Malabsorption Syndrome Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[吸収不良症候群の世界市場規模・現状・予測2021年-2027年] (Global Malabsorption Syndrome Market Size, Status and Forecast 2021-2027 / QY21APR3532)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆